Related Experiment Video
Updated: Jun 11, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic
Nelson S Yee1, Weiqiang Zhou, Minsun Lee
1Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA. nelson-yee@uiowa.edu
Abstract:
The roles of transient receptor potential (TRP) cation channels in pancreatic tumorigenesis are essentially unknown. Here, we focus on the TRP melastatin-subfamily (TRPM) members. Expression of the thermally regulated transmembrane Ca(2+)-permeable channel TRPM8 is consistently up-regulated in human pancreatic adenocarcinoma cell lines and tissues. TRPM8-deficient pancreatic cancer cells have reduced ability of proliferation and cell cycle progression with elevated levels of cyclin-dependent kinase inhibitors. These results indicate that TRPM8 is aberrantly over-expressed in pancreatic adenocarcinoma and required for cellular proliferation, and they support further investigation of the potential of TRPM8 as a clinical biomarker and therapeutic target in pancreatic adenocarcinoma.
Insights
Transient Receptor Potential Melastatin 8 (TRPM8) channels are over-expressed in pancreatic cancer. TRPM8 is crucial for cancer cell proliferation, suggesting its potential as a biomarker and therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Channelopathies
Background:
- The role of Transient Receptor Potential (TRP) cation channels in pancreatic cancer development is largely unexplored.
- The TRP melastatin subfamily (TRPM) members are implicated in various cellular processes.
Purpose of the Study:
- To investigate the role of TRPM8 in pancreatic adenocarcinoma.
- To determine if TRPM8 expression is altered in pancreatic cancer.
- To assess the functional impact of TRPM8 on pancreatic cancer cell behavior.
Main Methods:
- Analysis of TRPM8 expression in human pancreatic adenocarcinoma cell lines and tissues.
- Functional studies using TRPM8-deficient pancreatic cancer cells.
- Cell proliferation assays and cell cycle analysis.
- Measurement of cyclin-dependent kinase inhibitors.
Main Results:
- TRPM8 expression is consistently upregulated in human pancreatic adenocarcinoma.
- TRPM8-deficient pancreatic cancer cells exhibit reduced proliferation and impaired cell cycle progression.
- Elevated levels of cyclin-dependent kinase inhibitors were observed in TRPM8-deficient cells.
Conclusions:
- TRPM8 is aberrantly over-expressed in pancreatic adenocarcinoma.
- TRPM8 is essential for pancreatic cancer cell proliferation.
- TRPM8 represents a potential clinical biomarker and therapeutic target for pancreatic adenocarcinoma.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Thermosensation
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
